Reachability: Checkpoint 7i, red bed building
Business hours: Monday - Friday by appointment
The most common malignant liver tumors include liver cell carcinoma (hepatocellular carcinoma, abbreviated "HCC") and bile duct carcinoma (cholangiocellular carcinoma, abbreviated CCC). Both tumors should not be confused with metastases from other types of cancer (e.g. liver metastases from colon cancer). HCC is the fifth most common type of tumor worldwide. In Austria, HCC with around 700 and CCC with around 300 new cases per year tend to be among the rarer types of cancer.
What is special about HCC is that it occurs in 80-90% of cases in cirrhosis of the liver. Liver cirrhosis is advanced scarring of the liver, which is usually caused by years of inflammation in the liver (viral hepatitis, fatty liver inflammation, alcohol, etc.
The circumstance of a tumor in a chronically ill organ (cirrhosis of the liver) makes the care of the affected patients complex and requires an experienced interdisciplinary team. Every new patient in the liver tumor outpatient clinic is therefore presented to the interdisciplinary tumor board. Furthermore, before any therapy decision is made, the liver function must be taken into account and the liver cirrhosis must also be adequately treated.
The goals and services of the liver tumor outpatient department are Diagnosis of masses/nodules/tumors of the liver Presentation and therapy evaluation of patients in the interdisciplinary tumor board Organization and care before, during and after specific tumor therapies, e.g.
- Liver transplant
- Liver resection
- Radio Frequency Ablation (RFA) or Microwave Ablation (MWA)
- Transarterial chemoembolization (TACE)
- Medical therapy
- Organization and implementation of palliative and supportive care
Execution of clinical-scientific (drug) studies